Abzena

About Abzena

Abzena is a bioconjugate- and biologics-focused CDMO that pushes development of novel treatments forward at every stage from discovery through commercial launch. With the ability to tailor its strategy and customer experience to each project, Abzena develops and implements innovative solutions that enable biotech and biopharma companies to realize the full potential of their investments in human health. The company has research, development, and cGMP facilities across locations in San Diego, CA, Bristol, PA, and Cambridge, UK. Learn more at abzena.com

  • US
  • 2018
    On CPHI since
  • 250 - 499
    Employees
Company types
CMO/CDMO
Primary activities
Contract Research Organisation
Contact info
  • 6325 Lusk Blvd. , 92121, San Diego, CA, United States
Meet us at

CPHI Milan 2024

Fiera Milano, Italy
08 Oct 2024 - 10 Oct 2024

Products from Abzena (3)

  • Bioconjugation & Complex Chemistry Development and Manufacturing

    Product Bioconjugation & Complex Chemistry Development and Manufacturing

    Specialized ADC, bioconjugate and linker payload services. Moving medicines created with ADCs, bioconjugates and linker payloads forward is where we’re at our best. And it’s made Abzena a leader in delivering on their promise. Building on the unmatched expertise of our scientists, the IP we’ve generated,...
  • Biologics process development and analytical method development

    Product Biologics process development and analytical method development

    Developing an efficient, scalable, validated, and cost-effective manufacturing process is essential for success in today’s competitive biologics markets. Whether you need assistance developing a new process, are improving existing processes, or are preparing to manufacture your product, you will benefit f...
  • Lead Discovery and design

    Product Lead Discovery and design

    Abzena’s antibody discovery team collaborates with you to build the foundations of a successful program and de-risk your development path. We deliver expert assessments of target molecules, immunization strategies and antibody screening cascades that inform your selection of the best candidates for develo...

Abzena Resources (2)